Showing results (1031-1040 of 1,069) with videos related to
Sort By:
Pageof 107
Urologic Oncology|December 9, 2019
Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapyPetros Grivas, Tarek A Bismar, Aijai S Alva, et al.Targeted Oncology|September 30, 2018
Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial CarcinomaAlice Tzeng, C Marcela Diaz-Montero, Patricia A Rayman, et al.Targeted Oncology|March 25, 2020
Blood Myeloid-Derived Suppressor Cells Correlate with Neutrophil-to-Lymphocyte Ratio and Overall Survival in Metastatic Urothelial CarcinomaIris Y Sheng, Claudia Marcela Diaz-Montero, Patricia Rayman, et al.The International Journal on Drug Policy|April 3, 2021
An application of agent-based modeling to explore the impact of decreasing incarceration rates and increasing drug treatment access on sero-discordant partnerships among people who inject drugsSabriya L Linton, Don C Des Jarlais, Joseph T Ornstein, et al.The Journal of Urology|May 19, 2010
Surgical margin status after robot assisted radical cystectomy: results from the International Robotic Cystectomy ConsortiumNicholas J Hellenthal, Abid Hussain, Paul E Andrews, et al.BJU International|June 26, 2010
Lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy ConsortiumNicholas J Hellenthal, Abid Hussain, Paul E Andrews, et al.Journal for Immunotherapy of Cancer|March 22, 2023
Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B)Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2022
Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A)Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, et al.The International Journal of Eating Disorders|February 14, 2019
Radcliffe ARFID Workgroup: Toward operationalization of research diagnostic criteria and directions for the fieldKamryn T Eddy, Stephanie G Harshman, Kendra R Becker, et al.Cancer Research|December 5, 2000
Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinomaC P Paweletz, D K Ornstein, M J Roth, et al.Pageof 107